Table 5 Life expectancy estimates at age 20 years, showing unadjusted and adjusted values (assuming 30 % mortality among those lost to follow-up), n = 9997
From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
| Â | Unadjusted | Adjusted |
|---|---|---|
eOx (SE) | eOx (SE) | |
Overall | 45.2 (0.66) | 37.5 (0.61) |
Sex | Â | Â |
Female | 40.1 (1.34) | 32.4 (1.12) |
Male | 47.0 (0.75) | 39.2 (0.72) |
History of IDU | Â | Â |
Yes | 28.2 (1.07) | 23.9 (0.96) |
No | 63.9 (0.92) | 52.3 (0.84) |
Aboriginal ancestry | Â | Â |
Yes | 19.1 (1.60) | 17.7 (1.49) |
No | 62.7 (1.12) | 51.2 (0.97) |
Baseline CD4 (cells/μL) |  |  |
<350 | 44.1 (0.77) | 36.3 (0.70) |
≥350 | 50.8 (1.35) | 43.5 (1.25) |
Year of ART initiation | Â | Â |
2000–2003 | 40.8 (1.05) | 30.8 (0.90) |
2004–2007 | 44.4 (1.04) | 38.6 (0.96) |
2008–2012 | 56.7 (1.43) | 54.2 (1.37) |